Abstract
The global outbreak of clade IIb mpox in 2022-2023 changed our understanding of the epidemiology and prevention of mpox, simultaneously highlighting inequities in access to vaccines, diagnostics, and therapeutics. With the recent multinational spread of clade Ib mpox, it is important to revisit these lessons to improve future response. In September 2024, an international mpox symposium was held at Johns Hopkins University to discuss what we have learned and how to better prepare for the future. Here we highlight perspectives from that meeting and priorities for future mpox research.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 270-273 |
| Number of pages | 4 |
| Journal | Journal of Infectious Diseases |
| Volume | 232 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 15 2025 |
Keywords
- diagnostics
- monkeypox
- mpox
- therapeutics
- transmission
- vaccines
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Mpox: What Have We Learned and How Do We Better Prepare for the Future?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS